Background: Bone metastasis with advance cancer stage forms approximately 85% of all cases. Breast cancer patients frequently suffer from bone pain, functional impairment due to bone metastasis which impacts negatively on their quality of life. Subjects and Methods: A retrospective study of breast cancer patients who have bone metastasis at diagnosis or developing bone metastasis during 5 years from breast cancer diagnosis (2011)(2012)(2013)(2014)(2015)(2016) and who received zometa 4 mg monthly in radiotherapy department was included and conducted in 2017. We reviewed 107 female with breast cancer diagnosed by bone scan and/or PET scan as cases of bone metastasis enrolled. Questionnaire was designed to document all variables besides, demographic data which contain (age, histopathology reading invasive ductal carcinoma, invasive lobular carcinoma or others, ER status, PR status, Her2neu status and lymph node status & stage, Onset of metastasis, Menopausal Status & finally No. of metastasis site). Results: We noticed that the highest percentage of patients diagnosed as bone metastasis were 45 years and more, and 86% of them were invasive ductal carcinoma; regarding hormonal status we noticed that ER, PR status was positive in 90.7% and 82.2% of cases respectively, Her2neu receptors were amplified in 26.2% of them, positive lymph nodes were seen positive in 80.4% of cases and 31.8% of them were shown (N3) stage; we noticed that the only risk factor of bone metastasis is PR+ significantly associated with lesions multiplicity (0.049). There is no significant association between ER, PR, Her2neu, lymph nodes and menopausal status and onset of bone metastasis, also age, ER, Her2neu, lymph nodes and menopausal status are not associated significantly with No. of metastatic lesions. Conclusion: PR+ is significantly associated with lesions multiplicity (0.049), which is considered as a risk factor of bone metastasis in our study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.